This is a demo store. No orders will be fulfilled.

Healthcare

Healthcare, the world's largest industry, is transforming faster than ever. The focus on outcomes based medicine and optimal health management of populations will result in major seismic shifts. Modernization and reform measures are being employed globally by public and private sector organizations to meet the growing need for healthcare. New technologies are being created, offering enormous promise to improve care delivery.

Our Transformational Health practice serves all key industry stakeholders through partnership models that provide access to high-quality content and our global team of industry experts. The practice includes Visionary Health, Life Sciences, Advanced Medical Technologies and Connected Health, focusing on evolving healthcare technologies and covering the entire industry spectrum

  1. 28 Oct 2013  |  Global  |  Customer Research

    Competing in the Global Contract Manufacturing Market

    What Pharmaceutical and Biotechnology Companies Want and How to Compete for their Business

    The overall objective of this study was to provide contract manufacturing organizations (CMOs) a sound basis for formulating an effective strategy to compete in the market, including areas of opportunities and threats. As far as the market dynamics and CMO selection are concerned, overall satisfaction and likelihood of contract renewal are in the 4...

    $10,000.00
  2. 15 Oct 2013  |  Global  |  Market Research

    A Product and Pipeline Analysis of the Latin American HIV, Chagas, Dengue, and Influenza H1N1 Therapeutics Markets

    High Incidence of Infectious Diseases Persists, While Treatment Options Remain Scarce

    Latin America presents many opportunities for the infectious diseases market. This market insight offers an overview of the human immunodeficiency virus (HIV), Chagas, dengue, and influenza H1N1 therapeutics markets in Latin America. General market trends are covered, and a competitive landscape, which highlights current drugs on the market as well...

    $3,950.00
  3. 08 Oct 2013  |  Global  |  Market Research

    Global Next Generation Sequencing Informatics Market

    Informatics Vendors Flock to Growth in Sequencing Adoption

    More than 100 companies participate in the global next generation sequencing (NGS) informatics market. This research service evaluates the market from 2012 to 2018. The research covers key market drivers and restraints, analysis of the changing competitive landscape, revenue forecasts, and the important trends that affect market growth. Also includ...

    $4,950.00
  4. 03 Sep 2013  |  Global  |  Technology Research

    Innovations in Allergy Treatment and Monitoring (Technical Insights)

    Therapy and Monitoring Advances Help Achieve Long-term Relief from Allergy

    The global human plasma-derived therapeutics market is expected to experience a surge in demand due to an increase in the awareness of diseases and therapeutic options. The plasma-derived therapeutics market is segmented into albumin, immunoglobulins, coagulation factors, and other haemotologicals. The segments are discussed with supporting informa...

    $4,950.00
  5. 08 Aug 2013  |  Global  |  Technology Research

    Technology Investment Opportunities in Systems Biology (Technical Insights)

    Modeling Innovation

    This research service analyzes the global trends in the systems biology with a focus on the current and prospective applications of this platform. This study brings together expert opinions around the core technological and growth opportunities for systems biology in the 2020 horizon, and the wide range of relevant disciplines converging to systems...

    $4,950.00
  6. 07 Aug 2013  |  Latin America  |  Market Research

    Global Pharmaceutical Contract Manufacturing Market

    Injectable Dose Formulations will Likely Spur the Growth of CMOs

    This research service presents an overview and analysis of the Latin American Contract Research Organization (CRO) market with a focus on Argentina, Brazil, and Mexico. It provides country revenue by phase, therapeutic type, and region. The study discusses key challenges and emerging market trends, while providing detailed information on support se...

    $12,000.00
  7. 30 Jul 2013  |  Global  |  Technology Research

    Next Generation Stent Technologies (Technical Insights)

    Milestones in stent technologies achieved through proper funding sources

    This research service (RS) is a study on the funding prospects in the stent market. Stents are one of the most breakthrough medical devices in the cardiology market. The RS delivers content on the prevalent investor climate in this industry, and attempts to shed light on different channels available for obtaining funds. Higher patient safety and hi...

    $4,950.00
  8. 12 Jul 2013  |  Latin America  |  Market Research

    Electronic Medical Records (EMR) Market in Brazil

    Increasing Needs of Clinical Systems Expands EMR Bringing Brazil to the Forefront in Latin America

    Brazilian EMR penetration, considering every implementation levelfrom basic, with just electronic prescriptions, to complex, with different clincial modulesreaches 8% of total local healthcare institutions. There are few sole EMR vendors in the market. The local healthcare information technology (HC IT) market stage drives providers to offer EMR ...

    $3,950.00
  9. 07 May 2013  |  Latin America  |  Market Research

    2013 Europe; New Product Innovation - Extremolyte Therapeutics for Allergies

    This research service focuses on insulin and non-insulin therapeutics for the treatment of type 1 and 2 diabetes in Latin America. The insulin and non-insulin markets will experience major changes within the next three years, due to the discovery of new drugs. Focus is currently placed on the development of molecules that can help with patients ad...

    $1,500.00
  10. 30 Apr 2013  |  Global  |  Market Research

    Outsourcing to CMOs in Emerging EconomiesBoon or Bane?

    Analyzing the Prospects of CMOs in Emerging Markets

    This issue of Vital Signs discusses the acquisition of Cellular Research by Beckton Dickinson, collabaration of Illumina and Asuragen on companion diagnostics, a landmark NIH study on blood pressure management, and drug price hikes.

    $1,500.00